Anteris Technologies Global Corp. key statistics and ratios
In fiscal 2025, Anteris Technologies Global Corp. had an operating margin of -4908.2% and a current ratio of 0.73. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|
| Gross margin | 46.8% | 70.3% | 75.0% |
| Operating margin | <−999% | <−999% | <−999% |
| Net margin | <−999% | <−999% | <−999% |
| Free-cash-flow margin | <−999% | <−999% | <−999% |
| Return on equity | −121.6% | — | −82.4% |
| Return on assets | −94.5% | −181.6% | −70.1% |
| Asset turnover | 0.03 | 0.04 | 0.02 |
| Current ratio | 4.51 | 0.73 | 14.20 |
| Debt to equity | 0.0% | — | 0.2% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m |
| R&D as % of revenue | >999% | >999% | >999% |
| SG&A as % of revenue | >999% | >999% | >999% |
| Capital spending as % of revenue | 83.8% | 102.1% | 87.2% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 42.4% | 61.2% | 62.8% | 76.1% | 71.3% | 70.6% | 76.9% | 76.9% |
| Operating margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Net margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Free-cash-flow margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Current ratio | — | 4.51 | 3.67 | 2.41 | 0.84 | 0.73 | 20.93 | 14.20 |
| Debt to equity | — | 0.0% | 0.1% | 0.1% | 0.7% | — | 0.0% | 0.0% |
| R&D as % of revenue | >999% | >999% | >999% | >999% | >999% | >999% | >999% | >999% |
| SG&A as % of revenue | 907.3% | >999% | >999% | 811.3% | >999% | >999% | >999% | 832.9% |
Financial health
- Short-term assets cover short-term liabilities $261m of assets due within a year against $18m of liabilities due within a year.
- Short-term assets cover long-term liabilities $261m short-term assets against $2m of longer-dated liabilities.
- More cash than debt $250m of cash against $47,000 of debt.
- Debt below 40% of shareholders' equity Debt is 0% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt −$86m of operating cash flow against $47,000 of debt.
- Operating profit covers interest at least five times over Operating income of −$106m against $183,000 of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Compare with peers
- Femasys Inc statistics
- Volitionrx LTD statistics
- Seastar Medical Holding Corp statistics
- Insight Molecular Diagnostics Inc. statistics
- Icecure Medical Ltd. statistics
Head to head: AVR vs FEMYAVR vs VNRXAVR vs ICU
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies